As of September 19, 2023, a group of four analysts has recently shared their insights on the performance of Precision BioSciences (NASDAQ:DTIL) stock over the past three months. These analysts have collectively established an average price target of $3.25 for the company’s stock, with a high estimate of $5.00 and a low estimate of $2.00.
The number of bullish ratings reflects the level of positivity expressed by the analysts towards the stock, while the number of bearish ratings indicates a more negative sentiment. In the case of Precision BioSciences, the ratings received in the last three months are as follows:
– Bullish: 4
– Somewhat Bullish: 0
– Indifferent: 0
– Somewhat Bearish: 0
– Bearish: 0
It is worth noting that the current average price target has witnessed a significant decrease of 65.17% compared to the previous average of $9.33. Analysts typically gather information from various sources, including company conference calls, meetings, financial statements, and discussions with key insiders, to formulate their assessments and recommendations.
Precision BioSciences, Inc.
Updated on: 19/09/2023
Debt to equity ratio: Strong Buy
Price to earnings ratio: Sell
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Strong Sell
4:00 PM (UTC)
Date:19 September, 2023
|Analyst / firm||Rating|
DTIL Stock Performance on September 19, 2023: Decrease of $0.05 or 3.97% with Factors Influencing Stock Price Decline
DTIL Stock Performance on September 19, 2023:
– Previous close: $0.41
– Opening price: $0.42
– Price range throughout the day: $0.41 – $0.43
– Trading volume: 6,236 (lower than the average volume of 994,242 over the past three months)
– Market capitalization: $48.5 million
– Last year’s earnings growth: -143.59%
– Current year’s earnings growth: +25.59%
– No information available for earnings growth in the next five years
– Last year’s revenue growth: -78.28%
– Revenue growth can vary from year to year in the biotechnology industry
P/E Ratio: NM (not meaningful)
Price/Sales Ratio: 4.17
Price/Book Ratio: 0.77
Stock Performance on September 19, 2023:
– Decrease of $0.05 or 3.97%
– Factors influencing stock price decline: market conditions, investor sentiment, or company-specific news
– Precision BioSciences operates in the biotechnology industry
– Corporate headquarters located in Durham, North Carolina
Next Reporting Date: November 14, 2023
EPS Forecast for Next Quarter: -$0.24
DTIL Stock Analysis: Potential +608.72% Increase According to Analysts Forecasts
DTIL stock, the ticker symbol for Precision BioSciences Inc, closed at a price of 0.42 on September 19, 2023. The 5 analysts offering 12-month price forecasts for DTIL have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 1.40. This suggests a potential increase of +608.72% from the last price.
The fact that the median estimate represents such a significant increase in value suggests that the analysts have a positive outlook on the future prospects of Precision BioSciences Inc. The current consensus among 5 polled investment analysts is to buy stock in DTIL. This rating has remained steady since September.
The current quarter’s earnings per share for DTIL is -$0.24, indicating a loss. However, the sales for the same period are $7.0 million, indicating revenue generation by Precision BioSciences Inc.
Investors should keep an eye on the reporting date for the current quarter, which is November 14. This will provide further insights into the financial performance of DTIL and may influence the stock’s future trajectory.
Overall, the performance of DTIL stock on September 19, 2023, was positive, with the potential for significant growth according to analysts’ price forecasts. However, investors should conduct their own research and consider all factors before making any investment decisions.